Personnel Moves Archives - Medical Design Sourcing

Bio-Rad names Roop Lakkaraju as CFO

Roop K. Lakkaraju, EVP and CFO of Bio-Rad [Image from LinkedIn]Bio-Rad today announced it appointed Roop K. Lakkaraju as EVP and chief financial officer, effective April 15.

Lakkaraju joins the clinical diagnostics and imaging systems company from Benchmark Electronics where he served as EVP and chief financial officer and was responsible for all finance-related functions since 2018.

“We are pleased to welcome Roop Lakkaraju as our new chief financial officer,” CEO and President Norman Schwartz said in a news release. “Roop’s extensive experience and track record in financial management, operations, mergers and acquisitions, and capital markets transactions will be instrumental in helping us shape and execute our financial strategy.”

Prior to his tenure at Benchmark, Lakkaraju held CFO and senior operational roles at several large, multinational companies, including Support.com and Solectron.

“I am excited to join Bio-Rad as its chief financial offic…

Insulet picks new CFO following McMillan’s move to 3M spinoff

Ana Maria Chadwick [Image courtesy of Insulet]Insulet (Nasdaq: PODD) + announced today that it appointed Ana Maria Chadwick as its new EVP, CFO and treasurer.

Chadwick’s appointment — which goes into effect on April 22, 2024 — follows an extensive search process conducted by Insulet. That search spanned nearly six months after former CFO Wayde McMillan left for 3M’s Solventum healthcare spinoff in October.

Lauren Budden served as interim CFO and treasurer following McMillan’s departure. Insulet plans for her to continue in her role as group VP, chief accounting officer and controller.

Chadwick now joins Acton, Massachusetts-based Insulet, a developer of automated insulin delivery technology, with more than 30 years of experience in propelling growth within organizations.

Get the full story at our sister site, Drug Delivery Business News.

After Intuitive, Shockwave and Avail, Daniel Hawkins is now CEO at AI-powered MRI software startup Vista.ai

Former Avail Medsystems CEO Daniel Hawkins is now president and CEO of Vista.ai. [Photo courtesy of Avail Medsystems]Avail Medsystems founder and former CEO Daniel Hawkins has a new job as president and CEO of MRI software startup Vista.ai.

Palo Alto, California-based Vista.ai (founded and incorporated as HeartVista) makes AI-guided software for automating magnetic resonance imaging (MRI) exams.

Vista.ai was founded by Chief Medical Officer Bob Hu, Chief Architect and Head of Research Juan Santos and Chief Technology Officer William Overall. Its advisory board includes Stanford University doctors and professors and the radiology chair at the University of Wisconsin–Madison.

The company won FDA 510(k) clearances for its HeartVista Workstation with RTHawk application software for the acquisition of real-time and accelerated images from GE Healthcare whole-body MRI systems in 2014, 2017 and 2017. In 2019, the FDA cleared the company’s AI-assisted One Cli…

Medtronic’s Respiratory Interventions unit president is leaving

Outgoing Medtronic Respiratory Interventions President Ariel Mactavish. [Image from Ariel Mactavish on LinkedIn]Ariel Mactavish, president of the Respiratory Interventions unit at Medtronic (NYSE: MDT) + , announced that she is departing her post at the medtech giant.

In a post on LinkedIn, Mactavish explained her decision to depart:

“After 12 rewarding years, I have decided to leave Medtronic and I want to take the opportunity [to] share my deepest gratitude for the amazing work of our team and their unwavering commitment to our patients and customers over the last several years together,” she wrote.

Mactavish’s departure comes shortly after Medtronic announced major changes within her unit. The company said last month that it plans to exit the ventilator market.

That decision came more than a year after Medtronic said it would spin off its Patient Monitoring and Respiratory Interventions b…

BD names new president of BD Surgery

President of BD Surgery Rian Seger [Image courtesy of BD]BD this week announced it appointed Rian Seger as president of BD Surgery, effective April 1.

Seger will be responsible for driving the global strategic, operational and commercial performance of BD Surgery and will report to EVP and President of Interventional Rick Byrd. He replaces Brooke Story who is stepping down to focus on personal matters.

Before becoming president of BD Surgery, Seger was VP and general manager of BD’s Medication Delivery Solutions business unit within the BD Medical segment.

“Rian has more than 20 years of executive experience with proven leadership capabilities that help address unmet needs in health care,” Byrd said in a news release. “Re-joining BD Surgery strongly aligns with Rian’s passion for driving better outcomes for surgeons and patients. With his wealth of experience and a proven track record of delivering results and developing teams, he will be well-suited …

Roman to move out of CEO post at 3M, successor named

3M CEO Mike Roman [Photo courtesy of 3M]3M (NYSE: MMM) + announced today that it selected William M. Brown to succeed Mike Roman as CEO.

Brown’s appointment to the corner office goes into effect on May 1, 2024. Roman will shift to the role of executive chair of 3M’s board of directors with the same effective date.

“Bill’s strong track record as a CEO for a global technology company makes him the right leader for 3M,” Roman said in a news release. “He brings a wealth of experience in strategic leadership, innovation, and operational excellence to 3M. I look forward to working with him to build on our momentum in my new role as executive chairman.”

News of the shift at the top of 3M comes at an interesting time, as the manufacturing giant prepares to spin off its Solventum healthcare business.

Brown, 61, previously served as chair and CEO at L3Harris Technologies, an a…

Natus Neuro taps Philips, Medtronic veteran as CEO

[Chris Landon portrait photo courtesy of Natus]Natus Medical (Middleton, Wisconsin) recently announced that a well-known executive in the Minneapolis-St. Paul medical device hub is the new CEO of its Natus Neuro business.

Chris Landon joined Natus last month after serving for four years as the president and GM of Image Guided Therapy Devices at Philips. Before Philips, Landon worked at Medtronic for 16 years. At the world’s largest medtech company, he held VP and GM roles in charge of degenerative spine treatment tech, biologics and diagnostics.

Landon is also vice chair of the board for the Medical Alley Association trade group in Minnesota.

The company said in a LinkedIn post: “With a proven track record of driving innovation and fostering patient-focused organizational culture, Chris’s leadership and expertise will propel our mission of advancing neurodiagnostics and improving patient outcomes around the globe to new heights.”

…

Endologix picks former Medtronic leader as new chief commercial officer

Endologix announced today that it appointed Mike Mathias as its new chief commercial officer (CCO), effective immediately.

Mathias brings 30 years of experience leading commercial organizations within the cardiovascular area. He most recently served as VP of commercial operations at Limflow. He held that role from 2022 until Inari Medical acquired the chronic limb-threatening ischemia (CLTI) treatment maker last year.

At Endologix, his role includes overseeing commercial operations for the artery disease treatment developer.

“Joining Endologix at such a critical juncture is an honor,” Mathias said in a news release. “I am excited to apply my experience to innovate and join the leadership team of a company that stands at the forefront of interventional vascular therapies. Together, we will work to enhance our commercial strategy, ensuring success for our commercial teams and the organization as a whole.”

Before LimFlow, Math…

Orthofix announces new president of Bone Growth Therapies

Jason Shallenberger, Orthofix’s new president of Bone Growth Therapies [Image courtesy of Orthofix]Orthofix Medical (NASDAQ:OFIX) is promoting from within to fill a new business president position at the company.

The Lewisville, Texax–base spine and ortho tech company announced today that it moving its Bone Growth Therapies business out from under the leadership of its Spine business.

Jason Shallenberger, previously the VP of U.S. sales and marketing for the Bone Growth Therapies business, is now Orthofix’s president of Bone Growth Therapies.

“Jason has led sales and marketing for this successful franchise for a number of years,” Orthofix President and CEO Massimo Calafiore said in a news release. “Under his guidance, the sales team has produced quarter-after-quarter of double-digit growth in 2023. I am confident he will do an amazing job as President and continue to contribute greatly to the success of Orthofix.”

Shallenberger said he wa…

Endoscopic ultrasound company EndoSound has a new CEO

New EndoSound CEO Scott Aldrich Jr. [Image from Scott Aldrich Jr. on LinkedIn]EndoSound announced today that it appointed Scott Aldrich Jr. as its new CEO in a move that went into effect on Feb. 1.

Dr. Stephen Steinberg, who previously served as president and CEO, remains on the Portland, Oregon–based company’s leadership team as chief medical officer.

Aldrich most recently served as an independent consultant focusing on medical device strategy, commercialization and operations. According to LinkedIn, he also served as VP of commercial & strategy at Motus GI from January 2023 to July 2023, having been VP of global marketing & strategy from September 2019 until the start of 2023.

In a news release, EndoSound said Aldrich brings operational and commercial leadership abilities paired with experience in both interventional gastroenterology and medical device imaging. His experience also spans startups and small/mid-cap companies, both privately an…

AbbVie president and COO to move into corner office

Robert Michael is slated to become AbbVie’s CEO in July 2024. [Image courtesy of AbbVie]

AbbVie (NYSE: ABBV) recently announced that its board of directors has decided to promote the company’s president and COO Robert A. Michael into the corner office.

Michael will succeed Richard A. Gonzalez, who is retiring as CEO on July 1. Gonzalez will stay as executive chair of AbbVie’s board.

“On behalf of AbbVie’s board, I am extremely excited that Rob has agreed to serve as AbbVie’s next CEO,” Gonzalez said in a Feb. 20 news release.

“As a key member of the executive leadership team, he has had a tremendous impact on AbbVie. From establishing our financial planning organization, to the development of our diversified business strategy, to successfully navigating the end of exclusivity for Humira in the U.S., Rob has been integral to AbbVie’s impact since…

Philips tabs Stryker controller as next CFO

Philips proposed to appoint Charlotte Hanneman as its next CFO. [Image courtesy of Philips]Philips (NYSE: PHG) + announced today that it proposes to appoint Charlotte Hanneman as a member of its management board as chief financial officer (CFO).

The Dutch medtech giant proposed to make the appointment effective on Oct. 1, 2024. It must submit its proposal to the annual general meeting of shareholders scheduled for May 7, 2024.

Philips expects to have Hanneman join as a member of its executive committee on June 1, 2024. This begins her induction and transition into the role as she succeeds current CFO Abhijit Bhattacharya on Oct. 1, following his retirement.

Roy Jakobs, CEO of Royal Philips said: “I would like to thank Abhijit for his significant contribution to the transformation of Philips into a health technology company. His dedication and leadership have made a major impact throughout his long 37-year career in…